Are you Dr. Yankner?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 36 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
Dept. Of Pathology - Nrb 858c
77 Louis Pasteur Avenue
Boston, MA 02115Phone+1 617-432-6800
Summary
- Dr. Bruce Yankner, MD is a board certified neurologist in Boston, Massachusetts. He is currently licensed to practice medicine in Massachusetts and California. He is a Professor of Genetics and Neurology at Harvard Medical School. Director of the Harvard Neurodegeneration Training Program. Co-Director of the Paul F. Glenn Center for the Biology of Aging..
Education & Training
- Brigham and Women's Hospital/Massachusetts General Hospital/Harvard Medical SchoolResidency, Neurology, 1984 - 1986
- Stanford Health Care-Sponsored Stanford UniversityResidency, Internal Medicine, 1982 - 1984
- Stanford University School of MedicineClass of 1982
Certifications & Licensure
- CA State Medical License 1983 - Present
- MA State Medical License 1987 - 2025
- American Board of Psychiatry and Neurology Neurology
Publications & Presentations
PubMed
- 1346 citationsGene regulation and DNA damage in the ageing human brain.Tao Lu, Ying Pan, Shyan Yuan Kao, Cheng Li, Isaac S. Kohane
Nature. 2004-06-24 - 885 citationsNeural mechanisms of ageing and cognitive declineNicholas A. Bishop, Tao Lu, Bruce A. Yankner
Nature. 2010-03-25 - 451 citationsDestabilization of beta catenin by mutations in presenilin-1 potentiates neuronal apoptosisZhuohua Zhang, Henrike Hartmann, Viet Minh Do, Dorothee Abramowski, Christine Sturchler-Pierrat
Nature. 1998-10-15
Press Mentions
- What Happens to the Brain After Age 40?November 1st, 2022
- To Learn More Quickly, Brain Cells Break Their DNASeptember 5th, 2021
- Wednesday Round up #32January 14th, 2021
- Join now to see all
Grant Support
- Training In The Molecular Biology Of NeurodegenerationNational Institute On Aging2001–2012
- Modeling The Aging EpigenomeOffice Of The Director, National Institutes Of Health2010–2011
- Epigenetic Analysis Of IPS Cell Models Of Aging And Alzheimer'S DiseaseNational Institute On Aging2009–2010
- The Role Of CDK5 In The DNA Damage Responce During Aging And NeurodegenerationNational Institute On Aging2006–2010
- DNA Damage And Neurodegeneration In The Aging BrainNational Institute On Aging2006–2010
- Genomic Analysis Of Human Aging And Cognitive DeclineNational Institute On Aging2007–2009
- Gene Regulation And DNA Damage In The Aging BrainNational Institute On Aging2006–2009
- Studies On The Mechanism Of Beta Amyloid NeurotoxicityNational Institute Of Neurological Disorders And Stroke2006–2007
- Genomic Analysis Of Human Aging And Cognitive DeclineNational Institute On Aging2006
- Gene Regulation And DNA Damage In The Aging BrainNational Institute On Aging2005
- Studies On The Mechanism Of Beta Amyloid NeurotoxicityNational Institute Of Neurological Disorders And Stroke2003–2005
- Regulation Of Amyloid Beta Protein By APOE &CholesterolNational Institute On Aging2000–2004
- Regulation Of The App/Notch Gamma SecretaseNational Institute On Aging2000–2003
- Mechanism Of Beta Amyloid NeurotoxicityNational Institute Of Neurological Disorders And Stroke1992–2001
- Mechanisms Of Neuronal Degeneration In Downs SyndromeNational Institute Of Neurological Disorders And Stroke1996–1998
- Conference On Molecular Mechanisms In Alzheimers DiseaseNational Institute On Aging1997
- Amyloid Neurotoxicity And Biological FunctionNational Institute On Aging1990–1994
- Gene Therapy In The Nervous System Using RetrovirusesNational Institute Of Neurological Disorders And Stroke1987–1991